Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients.

Georgery, Hélène;Devresse, Arnaud;Yombi, Jean Cyr;Belkhir, Leïla;Kanaan, Nada;et.al.
(2021) Transplantation — Vol. 105, n° 12, p. e283-e284 (2021)

Files

Georgery-2021inpress-Disappointingimmunizationrate.pdf
  • Open Access
  • Adobe PDF
  • 793.97 KB
Download
Georgery-2021-Disappointingimmunizationrate.pdf
  • Open Access
  • Adobe PDF
  • 353.55 KB
Download

Details

Authors
Show more
Abstract
(en) Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is actively ongoing around the world to prevent coronavirus disease (COVID-19) infection that may be associated with dramatic outcomes, particularly in kidney transplant recipients (KTRs). We recently published a very low humoral response rate at 3.8% (n=3/78), 28 d after a single dose of the BNT162b2 vaccine (Pfizer-BioNTech). [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Georgery, H., Devresse, A., Yombi, J. C., Belkhir, L., De Greef, J., Darius, T., Buemi, A., Scohy, A., Kabamba-Mukadi, B., Goffin, E., & Kanaan, N. (2021). Disappointing Immunization Rate After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients. Transplantation, 105(12), e283-e284. https://doi.org/10.1097/TP.0000000000003861 (Original work published 2021)